Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/12/2017
EU: Chinese Biopharma R&D Investment Growth Highest Globally at 27...
2/12/2017
Data Snapshot - Hospital Consumption COPD Drugs in Shanghai
2/10/2017
Baidu Withdraws from Mobile Healthcare to Focus on AI-enabled Services
2/9/2017
Recent Executive Moves
2/9/2017
State Council Issues Major Pharma Industry Reform Policy
2/9/2017
Listed Chinese Pharma Companies Forecast Higher Earnings in 2016
2/8/2017
Deutsche Bank Expects Substantial mAb Market Growth in China
2/8/2017
Yangshibang Raises CNY 110M in Fosun-led Series B Financing
2/8/2017
China Will Continue To Rise As A Key Base for Global Pharmaceutical Ma...
2/7/2017
Sirnaomics Initiates a Clinical Phase IIa Study of Its siRNA Drug Cand...
2/7/2017
PwC: Chinese Hospital M&A Review and Outlook H1/2016
2/7/2017
Survey: 33% of Chinese Pharma Marketers Will Spend 20%+ on Digital Cha...
2/6/2017
Mobile Medical Healthcare Trends in China
2/6/2017
NHFPC Issues New Policy for Trial of Medical Consortiums
2/3/2017
Recent Executive Moves
2/2/2017
FirboGen Posts Positive Chinese Phase III Data for AZ-Partnered Anemia...
2/2/2017
Wuxi PharmaTechs CMO Subsidiary Expands Facility in Changzhou
2/2/2017
Trump Wants Big Pharma Cut Outsourcing and Prices, Promising Loosened ...
2/2/2017
Tough and Turbulent Time Ahead in the Coming Year of Trump Rooster - 2...
2/1/2017
Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
1/27/2017
China Healthcare Investment Cools But Remains Impressive
1/26/2017
2016 Compliance Enforcement in the Pharmaceutical Industry
1/25/2017
China's Fast Growing Life Sciences Sector Prepared to Compete for Expe...
1/25/2017
China to Issue A Major Reform Policy Covering Full Process of Drug Ind...
1/24/2017
Are Reforms Focused on Pharma Kickbacks in China, the Last Straw to Pu...
1/23/2017
Chinese Antibody Drug Developer Mabworks Raises $39M in Series B Round...
1/23/2017
China Reduces Import Duties of 22 APIs to Zero
1/23/2017
The State Council Withdraws Three Local Pharma Approval Requirements, ...
1/22/2017
Legochem Licenses China Right of Novel Antibiotic to RMX Biopharma
1/22/2017
WuXi AppTec Acquires CRO HD Biosciences
Page:
167
/
334
Total number of articles:
10002
:
[First]
[<<]
[165]
[166]
[167]
[168]
[169]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit